Geron Corp (NASDAQ:GERN) has a beta value of 0.51 and has seen 1.04 million shares traded in the recent trading session. The company, currently valued at $2.46B, closed the recent trade at $4.06 per share which meant it lost -$0.04 on the day or -0.89% during that session. The GERN stock price is -31.53% off its 52-week high price of $5.34 and 59.61% above the 52-week low of $1.64. If we look at the company’s 10-day average daily trading volume, we find that it stood at 9.78 million shares traded. The 3-month trading volume is 8.58 million shares.
The consensus among analysts is that Geron Corp (GERN) is Buy stock at the moment, with a recommendation rating of 1.10. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 5 have rated it as a Hold, with 4 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.05.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Geron Corp (NASDAQ:GERN) trade information
Sporting -0.89% in the red today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the GERN stock price touched $4.06 or saw a rise of 3.33%. Year-to-date, Geron Corp shares have moved 92.59%, while the 5-day performance has seen it change 7.22%. Over the past 30 days, the shares of Geron Corp (NASDAQ:GERN) have changed -3.71%. Short interest in the company has seen 76.24 million shares shorted with days to cover at 11.2.
Wall Street analysts have a consensus price target for the stock at $6, which means that the shares’ value could jump 32.33% from the levels at last check today. The projected low price target is $4.5 while the price target rests at a high of $8.0. In that case, then, we find that the latest price level in today’s session is -97.04% off the targeted high while a plunge would see the stock gain -10.84% from the levels at last check today.
Geron Corp (GERN) estimates and forecasts
Figures show that Geron Corp shares have outperformed across the wider relevant industry. The company’s shares have gained 22.40% over the past 6 months, with this year growth rate of 21.88%, compared to 17.90% for the industry. Revenue growth from the last financial year stood is estimated to be 38,528.53%.
8 analysts offering their estimates for the company have set an average revenue estimate of 62.16M for the current quarter. 6 have an estimated revenue figure of 55.73M for the next ending quarter. Year-ago sales stood 23k and 304k respectively for this quarter and the next, and analysts expect sales will grow by 270,172.24% for the current quarter and 38,528.53% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -16.08% over the past 5 years. Earnings growth for 2024 is a modest 17.85% while over the next 5 years, the company’s earnings are expected to increase by 5.00%.
GERN Dividends
Geron Corp is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Geron Corp (NASDAQ:GERN)’s Major holders
Insiders own 0.09% of the company shares, while shares held by institutions stand at 85.33% with a share float percentage of 85.40%. Investors are also buoyed by the number of investors in a company, with Geron Corp having a total of 337.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 46.55 million shares worth more than $197.38 million. As of 2024-06-30, BLACKROCK INC. held 7.7138% of shares outstanding.
The other major institutional holder is RA CAPITAL MANAGEMENT, L.P., with the holding of over 46.2 million shares as of 2024-06-30. The firm’s total holdings are worth over $195.9 million and represent 7.6558% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF. As of Jun 30, 2024, the former fund manager holds about 2.95% shares in the company for having 17.81 shares of worth $72.21 million while later fund manager owns 16.37 shares of worth $66.37 million as of Sep 30, 2024, which makes it owner of about 2.71% of company’s outstanding stock.
